Breast Cancer Meeting Highlights - Page 2 - HER2 Support Group Forums

		HER2 Support Group Forums
Breast Cancer Meeting Highlights

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Page 2 of 14

Last »

Threads in Forum : Breast Cancer Meeting Highlights

Forum Tools

Search this Forum

Rating Thread / Thread Starter	Last Post	Replies	Views
Her2 Posters Utilizing VeraTag Assays to be presented at SABCS Hopeful	12-12-2007 02:51 PM by Hopeful	0	2,008
BC patients w/1-3 positive nodes and low risk 70-gene profile have excellent survival Hopeful	12-17-2007 08:23 AM by Hopeful	0	1,391
Her2 Recurrence Rates pre-Herceptin Hopeful	12-16-2007 02:40 PM by Andrea Barnett Budin	9	2,702
Comparison of joint problems as reported by patients in a randomised adjuvant trial Hopeful	12-14-2007 02:43 PM by Hopeful	0	1,632
Impact of ERBB2 on prognosis and microarray data Hopeful	12-14-2007 02:45 PM by Hopeful	0	1,657
The clinical significance of polysomy 17 in the HER2+ N9831 intergroup adjuvant trast Hopeful	12-14-2007 02:48 PM by Hopeful	0	1,609
Mechanism of action of herceptin killing of HER-2+ breast cancer cells under in vitro Hopeful	12-14-2007 02:49 PM by Hopeful	0	1,638
AI's in early breast cancer toxicity and adherence Hopeful	12-14-2007 03:14 PM by Hopeful	0	1,915
Change in annual recurrence rates over the last 10 years - NORA study Hopeful	12-14-2007 03:36 PM by Hopeful	0	1,925
Confirmatory Tissue Biopsy for BC mets strongly recommended Hopeful	12-17-2007 08:25 AM by Hopeful	0	1,314
Multidisciplinary management of menopause symptoms after breast cancer Hopeful	12-17-2007 08:27 AM by Hopeful	0	1,233
For R.B - Her2 and fatty acid synthase in bc cells Hopeful	12-17-2007 08:29 AM by Hopeful	0	1,394
San Antonio Abstracts on line Early Hopeful	12-02-2008 09:42 AM by Hopeful	0	1,213
Determination of HER2 amplification - when should chromosome 17 also be determined Hopeful	12-14-2008 05:55 PM by Becky	2	1,946
BC patients unknowingly dosing themselves with estrogen by using topical moisturizers Hopeful	12-28-2008 01:28 PM by Rich66	9	2,686
A novel breast tissue feature strongly associated with risk of breast cancer Hopeful	12-10-2008 07:30 AM by Hopeful	0	1,730
HER-2 expression on circulating tumor cells in metastatic breast cancer Hopeful	12-10-2008 07:31 AM by Hopeful	0	1,494
Behaviour and metastatic potential of Her2+ and Her2-(CETC) during adjuvant therapy Hopeful	12-10-2008 07:34 AM by Hopeful	0	1,411
Metastatic potential of Her2+ and Her2- CETC released during primary systemic chemo Hopeful	12-11-2008 07:36 AM by Hopeful	0	1,447
Is metabolic syndrome the link between obesity and postmenopausal breast cancer? Hopeful	12-11-2008 07:38 AM by Hopeful	0	1,567
Promoter hypermethylation is an early event in breast carcinogenesis Hopeful	12-11-2008 07:40 AM by Hopeful	0	1,493
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathologica Hopeful	12-11-2008 07:44 AM by Hopeful	0	1,380
Remarkable complete pathologic response rate in Her2+ stage II/III pts in phase II tr Hopeful	12-11-2008 07:47 AM by Hopeful	0	1,700
HER-2/neu expression/amplification is not stable during tumor progression Hopeful	12-12-2008 07:47 AM by Hopeful	0	1,558
PR receptor levels are associated with time to AI treatment failure Hopeful	12-12-2008 07:49 AM by Hopeful	0	1,711
HER2 amplification does not alter outcome in small (1 cm) tumors Hopeful	12-12-2008 07:50 AM by Hopeful	0	1,577
HER2 amplification predicts breast cancer recurrence but not overall survival Hopeful	02-03-2009 09:30 PM by gdpawel	3	2,527
Low penetrance breast cancer predisposition SNPs are site specific Hopeful	12-12-2008 07:52 AM by Hopeful	0	2,050
Pooled cardiac safety analysis of patients with HER2+ MBC receiving trastuzumab Hopeful	12-12-2008 07:54 AM by Hopeful	0	1,649
Chronobiological rhythms of cytokines level of breast cancer Hopeful	03-19-2009 07:00 AM by Hopeful	0	1,766
Presence of an in-situ component is associated with reduced biological aggressiveness Hopeful	03-18-2009 06:17 AM by Hopeful	0	1,596
The coamplification pattern of HER2/NEU amplicon and its clinical significance Hopeful	03-18-2009 06:18 AM by Hopeful	0	1,491
Tumor size vs Her2 amplification in post-meno, ER+ tamoxifen tx pts Hopeful	03-18-2009 06:22 AM by Hopeful	0	1,706
CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcome Hopeful	03-18-2009 06:23 AM by Hopeful	0	1,521
The timing of recurrence after the surgery of breast cancer Hopeful	03-18-2009 06:24 AM by Hopeful	0	1,820
Is there a promotion of metastasis by autologeous breast reconstruction in patients? Hopeful	03-18-2009 06:25 AM by Hopeful	0	1,690
Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiother Hopeful	03-19-2009 06:52 AM by Hopeful	0	1,700
Radiofrequency ablation of early breast cancer followed by delayed surgical resection Hopeful	03-19-2009 06:53 AM by Hopeful	0	1,571
Primary endocrine therapy versus chemo in postmen pts w/ ER+ bc: 5 yr results Hopeful	03-19-2009 07:02 AM by Hopeful	0	1,703
Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer pts Hopeful	03-19-2009 07:04 AM by Hopeful	0	1,805
Combined ER and HER-targeted therapy in breast cancer treatment Hopeful	03-21-2009 10:23 PM by Jackie07	1	1,963
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen Hopeful	05-19-2009 06:32 AM by Hopeful	0	1,533
Treatment of node-negative infra-centimetric HER2+ invasive breast carcinomas Hopeful	05-19-2009 06:33 AM by Hopeful	0	1,428
PIK3CA gene expression signature and prognosis within the luminal-B ER+ bc Hopeful	05-19-2009 06:36 AM by Hopeful	0	1,646
Expression profile of CTC and corresponding tumors in primary breast cancer patients Hopeful	05-19-2009 06:38 AM by Hopeful	0	1,672
trastuzumab-related cardiac dysfunction in the HERA Trial with 3.6 years follow- up Hopeful	05-19-2009 06:40 AM by Hopeful	0	1,696
trial of acupuncture for the management of AI associated joint symptoms Hopeful	05-19-2009 06:41 AM by Hopeful	0	1,515
Association between HER2/neu overexpression and calcifications in breast cancer Hopeful	05-20-2009 06:23 AM by Hopeful	0	1,528
Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy Hopeful	05-20-2009 06:26 AM by Hopeful	0	2,074
Risk factors associated with trastuzumab-associated cardiac toxicity Hopeful	05-20-2009 06:28 AM by Hopeful	0	1,676
HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer Hopeful	05-20-2009 06:30 AM by Hopeful	0	1,555
Long-term follow-up and factors of survival of HER-2 positive breast cancer patients Hopeful	05-20-2009 06:31 AM by Hopeful	0	1,640
Response to neoadjuvant chemotherapy and outcome based on breast cancer subtype Hopeful	05-20-2009 08:24 AM by bejuce	1	1,883
Trastuzumab cardiotoxicity: FDA review Hopeful	05-21-2009 06:44 AM by Hopeful	0	1,668
Sensitivity to endocrine therapy of PR+/ER- patients and ER+/PR- patients with HER2+ Hopeful	05-21-2009 06:46 AM by Hopeful	0	1,639
Weight gain after adjuvant TAC (docetaxel, doxorubicin, and cyclophosphamide) chemo Hopeful	05-21-2009 06:50 AM by Hopeful	0	1,980
Surgery vs primary endocrine therapy for elderly women Hopeful	05-21-2009 06:51 AM by Hopeful	0	1,568
Off-label drug use in women with breast cancer Hopeful	05-21-2009 06:59 AM by Hopeful	0	1,693
Pertuzumab monotherapy following trastuzumab-based treatment Hopeful	05-28-2009 12:39 AM by Rich66	1	1,215
Complications associated with erythropoietin stimulating agents in mbc patients Hopeful	05-22-2009 06:41 AM by Hopeful	0	1,396
Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in Hopeful	05-22-2009 06:44 AM by Hopeful	0	1,230
Characteristics of subsequent breast cancers in patients with benign breast disease Hopeful	06-01-2009 07:34 AM by Hopeful	0	1,074
What is the evidence for rechallenging with anthracyclines or taxanes in MBC? Hopeful	06-01-2009 07:39 AM by Hopeful	0	1,052
Differential timing and patterns of recurrence among breast cancer subtypes Hopeful	06-01-2009 07:40 AM by Hopeful	0	1,016
Impressive survival data with semimetronomic oral chemo Hopeful	06-02-2009 07:06 AM by Hopeful	0	930
Cardiac safety of the lapatinib/letrozole combination Hopeful	06-02-2009 07:08 AM by Hopeful	0	1,122
Concordant HER2 status between malignant CSF cells and primary breast carcinoma tissu Hopeful	06-02-2009 07:10 AM by Hopeful	0	1,055
Multifactorial CNS relapse susceptibility in HER2-positive breast cancer patients Hopeful	06-02-2009 07:12 AM by Hopeful	0	983
CA 125 in the early detection of metastatic breast cancer Hopeful	06-02-2009 07:15 AM by Hopeful	0	791
Detection of locally advanced breast cancer in the I-SPY TRIAL Hopeful	06-03-2009 06:34 AM by Hopeful	0	710
A study of lavender and tea tree oils on postmenopausal FSH levels and hot flash seve Hopeful	06-03-2009 07:26 PM by Laurel	1	1,088
Effect of simvastatin on the pharmacokinetics of anastrozole Hopeful	06-03-2009 06:38 AM by Hopeful	0	761
Evaluation of the effect of screening on the detection of good and poor prognosis bc Hopeful	06-04-2009 06:22 AM by Hopeful	0	825
Factors leading to the decision for contralateral prophylactic mastectomy Hopeful	06-04-2009 06:23 AM by Hopeful	0	845
Neuroprotective effect of SSRI among 781 cancer patients receiving chemotherapy Hopeful	06-04-2009 06:26 AM by Hopeful	0	870

Page 2 of 14

Last »

	New posts		Hot thread with new posts
	No new posts		Hot thread with no new posts
	Thread is closed

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 07:44 AM.